The Australian government has announced that it is rescheduling psilocybin (magic mushrooms) and MDMA to allow for medical use for those with post-traumatic stress disorder (PTSD) and treat-resistant depression.
The country is moving the substances to Schedule 8 under the country’s drug code, allowing psychiatrists to prescribe them for medical and therapeutic uses. The substances will remain in the stricter Schedule 9 for non-medical use.
“The decision acknowledges the current lack of options for patients with specific treatment-resistant mental illnesses,” said Australia’s Therapeutic Goods Administration (TGA) on Friday. “It means that psilocybin and MDMA can be used therapeutically in a controlled medical setting starting on July 1. However, patients may be vulnerable during psychedelic-assisted psychotherapy, requiring controls to protect these patients.”
Continue reading